Schroder Investment Management Group’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.8M Buy
298,372
+178,414
+149% +$21.6M 0.02% 453
2026
Q1
$19.6M Buy
119,958
+52,569
+78% +$8.08M 0.02% 538
2025
Q4
$11.7M Sell
67,389
-3,532
-5% -$645K 0.01% 612
2025
Q3
$10M Sell
70,921
-16,694
-19% -$2.05M 0.01% 663
2025
Q2
$8.82M Sell
87,615
-39,880
-31% -$3.05M 0.01% 657
2025
Q1
$9.94M Sell
127,495
-140,568
-52% -$10.8M 0.01% 643
2024
Q4
$18.5M Buy
268,063
+127,641
+91% +$9.19M 0.02% 528
2024
Q3
$10.2M Sell
140,422
-56,495
-29% -$4.17M 0.01% 659
2024
Q2
$13.2M Buy
196,917
+156,817
+391% +$6.08M 0.01% 582
2024
Q1
$1.09M Hold
40,100
﹤0.01% 1011
2023
Q4
$1.24M Buy
+40,100
New +$1.04M ﹤0.01% 982

Other funds holding INSM

Schroder Investment Management Group's INSM Position: Q2 2026 in Review

Schroder Investment Management Group increased its Insmed (INSM) stake by 149% in Q2 2026, buying an estimated $21.6M and bringing the position to 298,372 shares worth $31.8M. The position accounts for 0.02% of the portfolio, ranked #453.

Schroder Investment Management Group first reported a position in INSM in Q4 2023 and has held it in 11 quarters since. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Schroder Investment Management Group held 298,372 shares of Insmed worth $31.8M as of Q2 2026.
  • Schroder Investment Management Group bought 178,414 Insmed shares in Q2 2026, an estimated $21.6M.
  • Insmed made up 0.02% of Schroder Investment Management Group's portfolio in Q2 2026, its #453 holding.
  • Schroder Investment Management Group first reported a position in Insmed in Q4 2023 and has held it in 11 quarters since.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.